
Eric Olson
Examiner (ID: 316, Phone: (571)272-9051 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1693, 1673, 1623 |
| Total Applications | 1758 |
| Issued Applications | 971 |
| Pending Applications | 175 |
| Abandoned Applications | 632 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17702835
[patent_doc_number] => 20220202841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => DERMATOLOGICAL FORMULATIONS FOR TREATMENT OF DERMATITIS
[patent_app_type] => utility
[patent_app_number] => 17/559187
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6927
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17559187
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/559187 | DERMATOLOGICAL FORMULATIONS FOR TREATMENT OF DERMATITIS | Dec 21, 2021 | Pending |
Array
(
[id] => 19430944
[patent_doc_number] => 20240299442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => ANTIVIRAL AGENTS FOR PREVENTION OR TREATMENT OF PATHOLOGIES CAUSED BY ALPHA- AND/OR BETA-CORONAVIRUSES
[patent_app_type] => utility
[patent_app_number] => 18/268371
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4427
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18268371
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/268371 | ANTIVIRAL AGENTS FOR PREVENTION OR TREATMENT OF PATHOLOGIES CAUSED BY ALPHA- AND/OR BETA-CORONAVIRUSES | Dec 21, 2021 | Pending |
Array
(
[id] => 17945836
[patent_doc_number] => 20220332853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => MANUFACTURING PROCESS FOR CYCLODEXTRIN DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/555286
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29521
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17555286
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/555286 | MANUFACTURING PROCESS FOR CYCLODEXTRIN DERIVATIVES | Dec 16, 2021 | Abandoned |
Array
(
[id] => 17748113
[patent_doc_number] => 20220226316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => SYNERGISTIC COMBINATIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/527085
[patent_app_country] => US
[patent_app_date] => 2021-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25652
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17527085
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/527085 | SYNERGISTIC COMBINATIONS AND METHODS OF USE | Nov 14, 2021 | Abandoned |
Array
(
[id] => 17748112
[patent_doc_number] => 20220226315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => SYNERGISTIC COMBINATIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/527084
[patent_app_country] => US
[patent_app_date] => 2021-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17527084
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/527084 | SYNERGISTIC COMBINATIONS AND METHODS OF USE | Nov 14, 2021 | Abandoned |
Array
(
[id] => 17748114
[patent_doc_number] => 20220226317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => SYNERGISTIC COMBINATIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/527087
[patent_app_country] => US
[patent_app_date] => 2021-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25663
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17527087
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/527087 | SYNERGISTIC COMBINATIONS AND METHODS OF USE | Nov 14, 2021 | Abandoned |
Array
(
[id] => 19096364
[patent_doc_number] => 20240115591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING BILIARY TRACT CANCER USING DEVIMISTAT
[patent_app_type] => utility
[patent_app_number] => 18/251521
[patent_app_country] => US
[patent_app_date] => 2021-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16225
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251521
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/251521 | THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING BILIARY TRACT CANCER USING DEVIMISTAT | Nov 2, 2021 | Pending |
Array
(
[id] => 18877370
[patent_doc_number] => 20240000739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => COMPOSITION FOR USE IN TREATMENT OF A BIOFILM IN A SUBJECT
[patent_app_type] => utility
[patent_app_number] => 18/039035
[patent_app_country] => US
[patent_app_date] => 2021-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4745
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18039035
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/039035 | COMPOSITION FOR USE IN TREATMENT OF A BIOFILM IN A SUBJECT | Oct 29, 2021 | Pending |
Array
(
[id] => 18877370
[patent_doc_number] => 20240000739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => COMPOSITION FOR USE IN TREATMENT OF A BIOFILM IN A SUBJECT
[patent_app_type] => utility
[patent_app_number] => 18/039035
[patent_app_country] => US
[patent_app_date] => 2021-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4745
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18039035
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/039035 | COMPOSITION FOR USE IN TREATMENT OF A BIOFILM IN A SUBJECT | Oct 29, 2021 | Pending |
Array
(
[id] => 18877370
[patent_doc_number] => 20240000739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => COMPOSITION FOR USE IN TREATMENT OF A BIOFILM IN A SUBJECT
[patent_app_type] => utility
[patent_app_number] => 18/039035
[patent_app_country] => US
[patent_app_date] => 2021-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4745
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18039035
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/039035 | COMPOSITION FOR USE IN TREATMENT OF A BIOFILM IN A SUBJECT | Oct 29, 2021 | Pending |
Array
(
[id] => 17414018
[patent_doc_number] => 20220048922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => COMPOUNDS TARGETING PRMT5
[patent_app_type] => utility
[patent_app_number] => 17/452689
[patent_app_country] => US
[patent_app_date] => 2021-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59241
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17452689
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/452689 | COMPOUNDS TARGETING PRMT5 | Oct 27, 2021 | Abandoned |
Array
(
[id] => 17412712
[patent_doc_number] => 20220047616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => Method and Compositions for Treating HTLV-1 Virus Infection
[patent_app_type] => utility
[patent_app_number] => 17/512183
[patent_app_country] => US
[patent_app_date] => 2021-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17512183
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/512183 | Method and Compositions for Treating HTLV-1 Virus Infection | Oct 26, 2021 | Abandoned |
Array
(
[id] => 17398192
[patent_doc_number] => 20220040282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => LOW CONTAMINANT COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/510069
[patent_app_country] => US
[patent_app_date] => 2021-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17463
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17510069
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/510069 | LOW CONTAMINANT COMPOSITIONS | Oct 24, 2021 | Pending |
Array
(
[id] => 17398192
[patent_doc_number] => 20220040282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => LOW CONTAMINANT COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/510069
[patent_app_country] => US
[patent_app_date] => 2021-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17463
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17510069
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/510069 | LOW CONTAMINANT COMPOSITIONS | Oct 24, 2021 | Pending |
Array
(
[id] => 17727734
[patent_doc_number] => 11384109
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-12
[patent_title] => Method for separating phenolic acid glucoside compounds from
[patent_app_type] => utility
[patent_app_number] => 17/506985
[patent_app_country] => US
[patent_app_date] => 2021-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 3308
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 238
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17506985
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/506985 | Method for separating phenolic acid glucoside compounds from | Oct 20, 2021 | Issued |
Array
(
[id] => 19497892
[patent_doc_number] => 20240336910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-10
[patent_title] => BUFFER COMPOSITION FOR NUCLEIC ACID ISOLATION FOR COLUMN-BASED ONE-TUBE PCR, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/923177
[patent_app_country] => US
[patent_app_date] => 2021-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923177
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/923177 | BUFFER COMPOSITION FOR NUCLEIC ACID ISOLATION FOR COLUMN-BASED ONE-TUBE PCR, AND USE THEREOF | Oct 19, 2021 | Pending |
Array
(
[id] => 17532353
[patent_doc_number] => 20220110962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => ANALOGUES OF OLEUROPEIN AND OLEACEIN AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/500099
[patent_app_country] => US
[patent_app_date] => 2021-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24194
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17500099
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/500099 | Analogues of oleuropein and oleacein and uses thereof | Oct 12, 2021 | Issued |
Array
(
[id] => 17642323
[patent_doc_number] => 20220170061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => METHODS FOR PURIFICATION OF MESSENGER RNA
[patent_app_type] => utility
[patent_app_number] => 17/450506
[patent_app_country] => US
[patent_app_date] => 2021-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25831
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17450506
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/450506 | Methods for purification of messenger RNA | Oct 10, 2021 | Issued |
Array
(
[id] => 20328444
[patent_doc_number] => 12458701
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-04
[patent_title] => Bis (hydroxy benzylidene) cyclic ketone based tetra-aza corand
[patent_app_type] => utility
[patent_app_number] => 17/639918
[patent_app_country] => US
[patent_app_date] => 2021-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 26
[patent_no_of_words] => 3824
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17639918
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/639918 | Bis (hydroxy benzylidene) cyclic ketone based tetra-aza corand | Oct 5, 2021 | Issued |
Array
(
[id] => 17368768
[patent_doc_number] => 20220023820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => REGULATION OF DNA SYNTHESIS BY NUCLEOTIDES LINKED TO PROTECTING GROUPS
[patent_app_type] => utility
[patent_app_number] => 17/494320
[patent_app_country] => US
[patent_app_date] => 2021-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13462
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17494320
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/494320 | Regulation of DNA synthesis by nucleotides linked to protecting groups | Oct 4, 2021 | Issued |